This topic contains a solution. Click here to go to the answer

Author Question: The right of access to the services of a system is related to which of the following non-functional ... (Read 14 times)

nevelica

  • Hero Member
  • *****
  • Posts: 563
The right of access to the services of a system is related to which of the following non-functional requirements?
 
  A) reliability
  B) maintenance
  C) performance
  D) security

Question 2

The result of S/MIME encrypting the digest using DSS and the sender's private DSS key is the ________.
 
  A. digital signature B. envelope
   C. digest code D. mail extension



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Brummell1998

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

D

Answer to Question 2

A




nevelica

  • Member
  • Posts: 563
Reply 2 on: Jul 7, 2018
:D TYSM


emsimon14

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library